CVD Prevention in clinical practice (European Guidelines on)

Topics: Cardiovascular Disease Prevention - Risk Assessment and Management

Authors

Table of contents: Full Text (ESC Clinical Practice Guidelines)

The scope of the problem: Past and Future

• Scientific background, Practical aspects: coronary artery disease, Heart failure, Aortic aneurysm and dissection, Peripheral arterial disease, Stroke, Practical aspects: prevention and management of stroke

Prevention strategies and policy issues

• Scientific background, Practical aspects: policy issues, Prevention in clinical practice

How to evaluate scientific evidence

• Scientific background, What is "evidence"?, Grading of evidence, The problems of evidence and guidance, Practical aspects 

Priorities, total risk estimation, and objectives

• Introduction, Priorities, Total risk estimation, How do I assess risk ?

Principles of behaviour change and management of behavioural risk factors

• Scientific background, The physicians/caregiver-patient interaction as a means towards behavioural change, Specialized and multimodal interventions, Practical aspects: management of behavioural risk factors

Smoking

• Scientific background, Practical aspect: prevention and management of smoking

Nutrition

• Scientific background, Practical aspects: management

Overweight and obesity

• Scientific background, Body weight and risk, Which index of obesity is the best predictor of cardiovascular risk and cardiovascular risk factors-body mass index (BMI), waist circumference (WC), or waist-hip circumference ratio (WHR)?, Imaging and fat distribution, Practical aspects: managements of obesity and overweight, Physical activity and body weight, Diet and behavioural interventions, Drug treatment of overweight

Physical activity

• Scientific background, Estimating physical activity, Practical aspects: management

Heart rate

• Scientific background, Practical aspects: management

Blood pressure

• Scientific background, Risk stratification and target organ damage, Practical aspects: management of hypertension, Who to treat, How to treat, Antihypertensive drugs, Desirable blood pressure, Duration of treatment

Plasma lipids

• Scientific background, Practical aspects: management, Should statins be given to all persons with cardiovascular disease?

Diabetes

• Scientific background, Practical aspects: management

The metabolic syndrome

• Scientific background, Practical aspects: management

Psychosocial factors

• Scientific background, Practical aspects: management of psychosocial risk factors in clinical practice

Imflammation markers and haemostatic factors

• Scientific background

Genetic factors

• Family history: scientific background, Family history: practical aspects, Phenotypes: scientific background, Genotypes: scientific background, DNA-based tests for risk prediction, Practical aspects, DNA-based tests for risk prediction, Pharmacogenetics, Severe familial dyslipidaemias and coronary heart disease, Familial hypercholesterolaemia (FH), Familial combined hyperlipidaemia (FCH) , Familial high-density lipoprotein deficiency syndromes New imaging methods to detect asymptomatic individuals at high risk for cardiovascular events

Gender issues: cardiovascular disease prevention in women

• Scientific background, Practical aspects

Renal impairment as a risk factor in cardiovascular disease prevention

• Scientific background, Practical aspect: management

Cardioprotective drug therapy

• Scientific background, Antiplatelet therapies, B-Blockers, ACE inibitors, Anticoagulation, Practical aspects: management, Antiplatelet therapy: aspirin, Antiplatelet therapy: clopidogrel, B-Blockers, ACE inhibitors, Calcium channel blockers, Diuretics, Anticoagulation

Implementation strategies

• Scientific background, Barriers to the implementation of guidelines, Doctor-patient relationship, Practical aspects, Important arenas for training, Implementation strategies